189 (Clopidogrel Fig 3)
Clopidogrel Tablet
Product Images NDC 50090-6568
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 50090-6568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1 (Clopidogrel Figure 01)
Figure-2 (Clopidogrel Figure 02)
Figure-4 (Clopidogrel Figure 04)
This text appears to be a statistical evaluation of a medical study comparing the effects of a placebo and the drug clopidogrel. The study considers the number of deaths and the percentage reduction of risk associated with each treatment. The data suggests that clopidogrel resulted in fewer deaths compared to the placebo, with a 7% risk reduction. The study also mentions that all treated patients received aspirin, and provides a timeline of days since randomization.*
146 (Clopidogrel Figure 05)
Fig-7 (Clopidogrel Figure 07)
Figure-3 (Clopidogrel Figure 3)
Figure-6 (Clopidogrel Figure 6)
Figure-8 (Clopidogrel Figure 8)
Structure (Clopidogrel Structure)
Label Image (Lbl500906568)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
